Net improvement in intervention and control groups at 12 months
| Intervention group | Control group | Difference in net %better (95% CI)* | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total | No. better | No. worse | Net %better | Total | No. better | No. worse | Net %better | ||
| *Difference = value in intervention group minus value in control group. | |||||||||
| †Perceived change in medication use in last 6 months compared with use before then. | |||||||||
| For medication, preventers and relievers, “better” and “worse” denote less and more use respectively. | |||||||||
| Breathing since baseline | 86 | 50 | 5 | 52 | 76 | 24 | 6 | 24 | 29 (10 to 47) |
| Medication in last 6 months† | 89 | 33 | 13 | 22 | 79 | 29 | 16 | 16 | 6 (−15 to 27) |
| Preventer in last 4 weeks | 90 | 24 | 11 | 14 | 81 | 6 | 10 | −5 | 19 (4 to 35) |
| Reliever in last 4 weeks | 90 | 25 | 7 | 20 | 81 | 9 | 7 | 2 | 18 (2 to 33) |
| Wheeze in last 4 weeks | 89 | 22 | 7 | 17 | 81 | 20 | 4 | 20 | −3 (−19 to 12) |
| Wheeze disturbs sleep | 89 | 30 | 10 | 22 | 81 | 35 | 4 | 38 | −16 (−34 to 2) |
| Wheeze limits speech | 87 | 11 | 1 | 11 | 81 | 6 | 3 | 4 | 8 (−2 to 18) |
| Wheeze affects activities | 90 | 36 | 11 | 28 | 81 | 30 | 12 | 22 | 5 (−15 to 26) |
| Rhinitis | 90 | 22 | 6 | 18 | 81 | 7 | 12 | −6 | 24 (9 to 39) |
| Rhinoconjunctivitis | 90 | 21 | 7 | 16 | 81 | 8 | 12 | −5 | 20 (5 to 36) |
| Rhinitis affects activities | 90 | 28 | 17 | 12 | 81 | 17 | 18 | −1 | 13 (−7 to 33) |